Safety and Efficacy of Intravenous Cladribine in Multiple Sclerosis Patients

被引：0
|
作者：
Alchaki, Abdul Rahman [1 ]
Anadani, Nidhiben [2 ]
Cook, Stuart [3 ]
机构：
[1] Rutgers State Univ, Clifton, NJ USA
[2] Rutgers State Univ, Newark, NJ USA
[3] Rutgers State Univ, Newark, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P039
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Intravenous Cladribine in Patients with Rapidly Evolving or Early Secondary Progressive Multiple Sclerosis
    Alshamrani, Foziah
    Alnajashi, Hind
    Almuaigel, Mohammed F.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [2] Efficacy and safety of intravenous and subcutaneous cladribine in relapsing and progressive multiple sclerosis: a 24-year retrospective
    Ko, M.
    Katsamakis, G.
    Balabanov, R.
    Stefoski, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 532 - 533
  • [3] Ocrelizumab and Cladribine have Similar Efficacy and Safety in Naive Relapsing Remitting Multiple Sclerosis Patients
    Alroughani, R.
    Al-Hashel, J.
    Ahmed, S. Farouk
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 97 - 97
  • [4] New strategies to manage the safety of cladribine in patients with multiple sclerosis
    Reitano, Paola
    Chisari, Clara G.
    Patti, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [5] Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis
    Nabizadeh, Fardin
    Mohamadi, Mobin
    Rahmani, Shayan
    Rajabi, Rayan
    Afrashteh, Fatemeh
    Najdaghi, Soroush
    Mirmosayyeb, Omid
    NEUROLOGICAL SCIENCES, 2023, 44 (09) : 3045 - 3057
  • [6] Safety and efficacy of cladribine in multiple sclerosis: a systematic review and meta-analysis
    Fardin Nabizadeh
    Mobin Mohamadi
    Shayan Rahmani
    Rayan Rajabi
    Fatemeh Afrashteh
    Soroush Najdaghi
    Omid Mirmosayyeb
    Neurological Sciences, 2023, 44 : 3045 - 3057
  • [7] REAL WORLD DATA EVALUATING EFFICACY AND SAFETY OF ORAL CLADRIBINE FOR MULTIPLE SCLEROSIS
    Nasir, Moneeb
    Rabvukwa, Plaxedes
    Fuller, Sarah
    Chaudhuri, Abhijit
    Mattoscio, Miriam
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [8] Updated Safety Analysis of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis
    Cook, Stuart D.
    Giovannoni, Gavin
    Leist, Thomas P.
    Syed, Sana
    Nolting, Axel
    Damian, Doris
    Schick, Regina
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 54 - 55
  • [9] Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis
    Cook, S.
    Giovannoni, G.
    Leist, T.
    Syed, S.
    Nolting, A.
    Schick, R.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 465 - 466
  • [10] Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Giovannoni, Gavin
    Nolting, Axel
    Hicking, Christine
    Galazka, Andrew
    Sylvester, Elke
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 29 : 157 - 167
12345